These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9236188)

  • 1. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2.
    Gilkeson GS; Mudgett JS; Seldin MF; Ruiz P; Alexander AA; Misukonis MA; Pisetsky DS; Weinberg JB
    J Exp Med; 1997 Aug; 186(3):365-73. PubMed ID: 9236188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.
    Weinberg JB
    Environ Health Perspect; 1998 Oct; 106 Suppl 5(Suppl 5):1131-7. PubMed ID: 9788887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.
    Weinberg JB; Granger DL; Pisetsky DS; Seldin MF; Misukonis MA; Mason SN; Pippen AM; Ruiz P; Wood ER; Gilkeson GS
    J Exp Med; 1994 Feb; 179(2):651-60. PubMed ID: 7507509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice.
    Keng T; Privalle CT; Gilkeson GS; Weinberg JB
    Mol Med; 2000 Sep; 6(9):779-92. PubMed ID: 11071272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
    Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
    Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice.
    Hortelano S; Díaz-Guerra MJ; Gonzalez-García A; Leonardo E; Gamallo C; Boscá L; Martínez-A C
    J Immunol; 1997 Feb; 158(3):1402-8. PubMed ID: 9013985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Huang FP; Feng GJ; Lindop G; Stott DI; Liew FY
    J Exp Med; 1996 Apr; 183(4):1447-59. PubMed ID: 8666903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene.
    Njoku C; Self SE; Ruiz P; Hofbauer AF; Gilkeson GS; Oates JC
    J Investig Med; 2008 Oct; 56(7):911-9. PubMed ID: 18797415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice.
    Lui SL; Tsang R; Wong D; Chan KW; Chan TM; Fung PC; Lai KN
    Lupus; 2002; 11(7):411-8. PubMed ID: 12195781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice.
    Oates JC; Gilkeson GS
    J Investig Med; 2004 Jan; 52(1):62-71. PubMed ID: 14989372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase inhibits the development of autoimmune-mediated vasculitis in mice.
    Schoeb TR; Jarmi T; Hicks MJ; Henke S; Zarjou A; Suzuki H; Kramer P; Novak J; Agarwal A; Bullard DC
    Arthritis Rheum; 2012 Dec; 64(12):4114-24. PubMed ID: 22933338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice.
    Yu CC; Yang CW; Wu MS; Ko YC; Huang CT; Hong JJ; Huang CC
    J Lab Clin Med; 2001 Jul; 138(1):69-77. PubMed ID: 11433230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
    Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
    J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice.
    Weinberg JB; Gilkeson GS; Mason RP; Chamulitrat W
    Free Radic Biol Med; 1998 Jan; 24(1):191-6. PubMed ID: 9436630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists.
    Reilly CM; Oates JC; Cook JA; Morrow JD; Halushka PV; Gilkeson GS
    J Immunol; 2000 Feb; 164(3):1498-504. PubMed ID: 10640767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of late modulation of nitric oxide production on murine lupus.
    Oates JC; Ruiz P; Alexander A; Pippen AM; Gilkeson GS
    Clin Immunol Immunopathol; 1997 Apr; 83(1):86-92. PubMed ID: 9073540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
    Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
    J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
    Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
    J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of inflammatory arthritis and glomerulonephritis in congenic lpr mice and their F1 hybrids.
    Gilkeson GS; Ruiz P; Pritchard AJ; Pisetsky DS
    J Autoimmun; 1991 Aug; 4(4):595-606. PubMed ID: 1777011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H; Reilly CM; Molano ID; Garnier G; Circolo A; Ruiz P; Holers VM; Boackle SA; Gilkeson GS
    J Immunol; 2001 May; 166(10):6444-51. PubMed ID: 11342671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.